ELIVE MEDICAL LIMITED

ELIVE Medical Ltd is an innovative medical‑device company dedicated to tackling chronic heart failure – the leading cause of premature death in the Western world. Drawing on the combined expertise of a veteran cardiac surgeon, a stem‑cell researcher and a seasoned cardiac‑device executive, ELIVE has created ELIVE™ – Endogenous Laser‑Induced Ventricular Enhancement, a breakthrough trans‑catheter therapy that delivers a CO₂ laser directly to the beating heart via a highly flexible hollow‑fibre waveguide.

The ELIVE™ system comprises a disposable, trans‑femoral insertion catheter equipped with a CO₂ hollow‑fibre and supporting ferrule, allowing interventional cardiologists to perform a minimally invasive procedure in cath labs or modern hybrid operating rooms. By stimulating endogenous regeneration in ischaemic or hibernating myocardium, the therapy offers a viable option for patients who currently have no therapeutic alternative.

With a mission to improve the quality of life for the millions of people diagnosed with heart failure – a population that is growing by up to 5 % each year – ELIVE Medical is poised to reshape cardiac care through its cutting‑edge laser‑induced, stem‑cell‑enhanced treatment.